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Summary: This report summarizes an evaluation of the fully automated Olympus Hite System (AHS, Olympus,
D-2000 Hamburg) for serum protein fractionation. The precision thereof exceeded that of the semi-manually pro-
cessed Multiphorese System II MS 755 (Vogel, D-6300 Gießen). It proved to be rapid and easy to maintain. A com-
parison of the albumin values obtained by AHS and Beckman immunochemistry system showed a good correlation
between both methods.
Ein vollautomatisches Serum-Elektrophorese System
Zusammenfassung: Es wird über die Erprobung des vollautomatischen Olympus Hite Systems (AHS, Olympus,
D-2000 Hamburg) für die Serum-Protein-Fraktionierung berichtet. Die Präzision dieses Gerätes war besser als die eines
zum Vergleich verwendeten halb-mechanisierten Systems (Multiphorese System II MS 755 (Vogel, D-6300 Gießen).
Es erwies sich als rasch und einfach in der Bedienung. Ein Vergleich der Albuminwerte, welche mit dem AHS und dem
Beckman Immunochemistry System erhalten wurden, ergab eine gute Übereinstimmung beider Verfahren.
Introduction
Electrophoresis by separation of serum proteins on
cellulose^acetate membrane is widely used for the
clinical screening and monitoring of abnormal protein
patterns (1). The intricate semi-manually processed
techniques (2, 3), however, show poor duplication with
aliquots of the same specimens. In addition, interlabor-
atory variation, partly dependent on methodology,
showed deviant results, thus preventing comparison of
electrophofetic data from different laboratory centres.
The clinical diagnostic value of the former systems was
also diminished by the non-linearity between the relative
albumin arid globulin concentrations and total serum
protein concentrations (4). Furthermore, the handling
of the potential cancerpgen dioxan for membrane trans-
parency prior to densitornetry should be avoided (5).
The present study was undertaken to evaluate, according
to the recommendations of IFCC (6), the fully auto-
mated Hite^system (AHS, Olympus, D-2000 Hamburg),
to assess a series of reference values for healthy adults,
and to compare the albumin values obtained by the




Sera were randomly drawn from 200 hospitalized subjects and
tested in parallel using the AHS and the currently employed
semi-manually processed technique as described below. For
setting up the reference range, sera were obtained from 335
apparently healthy adults comprising 176 blood donors (age
range: 22-42 years, sex ratio: male/female, 3/2) and 159
healthy staff members (age range: 20-60 years) routinely
examined by personnel medical service. Laboratory information
about these individuals based on haemogram (erythrocyte and
leucocyte count, haemoglobin, haematocrit), aspartate amino-
transferase, alanine aminotransferase, 7-glutamyltransferase,
hepatitis B surface (HBS) antigen and anti-HBs-antibody yielded
normal values in all cases. All sera were tested within 48 h of
collection,
Electropherograms
the reagents of the AHS acetic acid (997 g/1) (No. 33209),
decahydionaphthalene (No. 803101) and granular activated
charcoal (No. 2515) were supplied by E. Merck (D-6100 Darm-
stadt), cellulose-acetate membranes (SM 11200) and 0.07 mol/1
sodium-barbital buffer pH 8.6 containing citric acid 50 g/l
(No. 14202) (diluted with 900 ml of bidistilled water for the
electrophoresis chamber; diluted with 1000 ml of bidistilled
water for the premoistening roller chamber) by Sartorius
(D-3400 Göttingen), heat sensitive recording paper (No.
60082) and Ponceau S 8 g/l in trichloroacetic acid 60 g/l
(No. 60098) by Olympus (D-2000 Hamburg). To obtain electro-
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phoretic patterns, 50 ìÀ of sera were pipetted onto capillary
blades of a sample plate, which was then set into the apparatus.
All successive, previously manually-processed steps, such as
serum application, switch on/off the power supply for the
electrophoresis chamber, staining, destaining, membrane
transparency, drying, densitometry and recording were per-
formed automatically.
For comparison, the electrophoretic patterns were displayed
by the semi-manually processed Multiphorese-System II
MS 755 (SMMS, Vogel, D-6300 Gie en). The reagent, 0.07
mol/1 sodium-barbital buffer pH 8.6 containing citric acid
(50 g/1) (diluted with 1000 ml of bidistilled water) (No. SM
14202) and cellulose-acetate membranes (No. SM 11200) were
purchased from Sartorius (D-3400 G ttingen). The electro-
phoresis chamber (No. 49002-01), multi-sample applicator for
simultaneous application of 8 samples (No. 49010-80) and the
staining solution, Amido Black 10 B (No. 49718-06), were
supplied by Instrumentation Laboratory GmbH (D-5303 Born-
heim-Hersel). The destaining reagents, acetic acid (997 g/1) (No.
33209) and methanol (No. 6009) mixed 1 + 9 by vol., as well
as the solution for transparency, dioxan/isobutanol (No. 3111),
were supplied by E. Merck (D-6100 Darmstadt).
Protein measurements
Albumin was quantitated by rate nephelometry (Beckman
Immunochemistry system (ICS), analyzer 662401) of the
immuno-precipitin reactions after adding monospecific anti-
human albumin serum (Beckman, D-8000 M nchen) to sera.
Total serum protein was determined by the biuret reaction (7).
Control materials
REL (catalogue No. CLK 6213) were purchased from Asid-
Bonz & Sohn (D-8044 Unterschlei heim), Precilip (catalogue
No. 125059) from Boehringer Mannheim (D-6800 Marinheim),
Kontrollogen L (catalogue No. ORTL 02057) from Behring-
Werke (D-3550 Marburg), Hyland N (catalogue No. HD-0450135)
and Hyland P (catalogue No. HD-045-119) from Hyland-Travenol
GmbH (D-8000 M nchen).
Statistical methods
Precision within-run and between-days (mean value: ÷, standard
deviation: S.D., coefficient of variation: C.V.) as well as the
x2 test for goodness of fit for the normal distribution, linear
regression analysis, standardized principle component analysis
(8) and Student's t-test (statistical difference from zero:
2 ñ < 0.05) were performed as described elsewhere (9).
assigned values. Constantly decreased values (between
18.5% to 34%) with regard to the assigned values were
found for the j3-globulin fraction. The relation between
total serum protein and den.sitometric results (linearity
test) was analyzed by diluting serially control materials
and sera with various total serum protein concentrations.
While no relevant relative deviation of densitometric
results (< 2%) was observed for all fractionated samples
with the AHS, a reduced range of linearity was found
with the SMMS, yielding an increase of the fraction of
albumin in relation to the degree of dilution (fig. 1).
The inaccuracy was further investigated by comparison
of the fractions of albumin and ã-globulin from various
healthy adults, using the AHS and the SMMS (fig. 2a, b).
The results indicate that the fractions of albumin and
7-globulin differed significantly between AHS and SMMS.
The albumin concentrations in various samples of healthy
adults were measured with the AHS, the SMMS and the
Beckman ICS respectively. The absolute albumin concen-
trations in samples tested by both electrophoretic systems
were calculated via the relative albumin values from total
serum protein (fig. 3a, b).
In contrast to the albumin values obtained with the
SMMS, those found with the ARS showed no significant
difference from that of the Beckman ICS. Based upon
these observations, it was compulsory to establish a
new reference range for AHS.
Cany over effects
The percental coefficient of carry over determined
according to Hjelm (10) was 0.84% for low to high
albumin values and 0.05% for high to low albumin
values. The ninhydrin colour reaction for the detection
of carried over proteins was negative (11). Therefore,
carry over for the AHS was concluded to be negligible.
Results and Discussion
Imprecision
The control materials fractionated by the AHS revealed
a lower within-run imprecision for albumin (C.V.:
0.75% to 0.98%) and ã-globulin (C.V.: 0.32% to 2.2%)
with respect to the SMMS (albumin, C.V.: 1,82% to
3.56%; 7-globulin, C.V.: 4.97% to 20.36%) (tab. 1, 2).
Furthermore, the latter system showed incomplete
separation in 4 out of 5 control materials. The between-
days imprecision (C.V.) for the AHS varied from 0.76%
to 1.78% for the albumin fraction and from 1.85% to
5.48% for the ã-globulin fraction (tab. 1).
Inaccuracy
The means in table 1 for the albumin, o^ -, o^-» and 7-
globulin fractions correlated sufficiently with the
Interference from endogeneous compounds
No interference was noticed from haemoglobin (up to
2.3 g/1), cholesterol (up to 11.9 mmol/1), triglycerides
(up to 12.37 mmol/1) and bilirubin (up to 259 ìôçïÀ/À)
in sera assayed by the AHS. However, the electrophor-
etic separation with the SMMS was incomplete for
haemolytic (haemoglobin above 0.5 g/1) and lipaemic
sera (cholesterol above 6.2 mmol/1, triglycerides above
2.84 mrnol/1). No interference was observed for bilirubin-
aemic sera using AHS and SMMS.
Interference from exogeneous compounds
Pooled sera from several patients.were spiked with 48
different drugs or anticoagulants in clinically relevant
concentrations (12) (tab. 3). The confidential range was
determined from 20 electrophoretic determinations in
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Tab. 1 . Precision data of the electrophoretically fractionated control materials determined with the AHS.
Protein fractions
Albumin áú -Globulin




























































































































































































































































*) ÷ = Protein fraction, mean value
C.Vi = Coefficient of variation (in %)
n = Number of determinations
2) ÷ = Protein fraction, mean value
C.V. = Coefficient of variation (in 7c)
ç = Number of days
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Tab. 2. Precision data of the electrophoretically fractionated control materials determined with the SMMS.
Protein fractions
Albumin é -Globulin <*2 -Globulin 0-Globulin











































































































































l) ÷ = Protein fraction, mean value
C.V. = Coefficient of variation (in %]
n = number of determinations
*i.s. = incomplete separation
the absence of any compounds. No interference, was
found with the tested antirheumatic, cytostatic, cardio-
active, antihypotonic and diuretic drugs. The recovery
of albumin in the presence of acidum ascorbicum and
chlordiazepoxidum was low. For the ar and a2-globulin
fractions, minor deviations outside the confidential range
were found in the presence of saUcylazosulphapyridinum,
indometacinum, acidum ascorbicum, dextranum 6%,
chloramphenicolum, benzbromaronum, acidum tri-
iodozoicum, allopurinolum, Na-fluoratum, Na-oxalicum,
and chlordiazepoxidum. At present any interference
from drugs and their clinical relevance must be ascer-
tained individually.
Reference range
Our results are mainly in agreement with the reported
ranges for albumin, ar, a2-, £ and ã-globulin fractions
from blood donors (4). Investigations on medical staff
yielded broader ranges, especially for the albumin and
i. din. Chem. CUn- Biochem. / Vol. 19,1981 / No. 6
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Fig. 1. Linerarity pattern of the albumin fraction with regard
to the degree of dilution (diluent: 0.15 mol/1 NaCl)
of the applied total serum protein in control materials
(e.g. Kontrollogen L, Hyland N i l , Hyland Ñ 11, ·) and
sera with various protein concentrations (total serum
protein: * < 55 g/1, · 60-75 g/l, o > 80 g/l) performing
ARS (—) and SMMS ( ).
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Fig. 2b. Correlation between the 7-globulin fractions obtained
by SMMS and AHS. Linear regression analysis:
slope = 0.89, intercept = 0.0169, r = 0.96, ÷ = 0.1557
S.D. = 0.0723, y = 0.1483, S.D. = 0.0632, ç = 200.
Standardized principle component analysis: slope = 0.87,















Fig. 2a. Correlation between the albumin fractions obtained by
SMMS and AHS. Linear regression analysis: slope =0.87,
intercept = 0.098, r = 0.95, ÷ = 0.5943, S.D. = 0.0962,
y = 0.6167, n = 200. Standardized principle component
analysis: slope = 0.92, intercept = 0.0687. Paired t-test:
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60.0
Fig. 3a. Correlation between the albumin concentrations (g/1)
obtained by Beckman ICS and AHS. Linear regression
analysis: slope = 0.99, intercept = 0.22, r = 0.99,
x = 39.48, S.D. = 9.31, y = 39.49, S.D. = 9.34, n = 61.
Standardized principle component analysis: slope = 1.00,
intercept = 0.12. Paired t-test: t = -0.07, 2p > 0.05.
ã-globulin fractions. Considering the lack of definitive
criteria for defining a population of apparently healthy
adults, we regarded those individuals as healthy, who
showed no uncommon data from anamnesis, physical
examination and 9 laboratory routine tests as described
in the methodology. We calculated the values of both
groups, thereby gaining a representative reference range
(tab. 4). We tested the null hypothesis that the albumin,
<*i-, <*2-> 0- and 7-globulin fractions fit a normal distribu-
tion. Since our computed ÷2 values were not significant
for albumin á2·> " anc* ã-globulin fractions at the 5%
significance level, we concluded that the null hypothesis
for these protein fractions has to be accepted. In the
case of the o^ -globulin fraction we had to reject the
null hypothesis, because the c^ -globulin fraction does
not follow a normal distribution (fig. 4),
J. Gin. Chem. Clin. Biochem. / Vol. 19,1981 / No. 6
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Fig. 3b. Correlation between the albumin concentrations (g/1)
obtained by Beckman ICS and SMMS. Linear regression
analysis: slope = 0.98, intercept = -Q.46, r = 0.96,
÷ = 39.39, S.D. = 9.24, y = 38.11, S.D. = 9.39, n = 61.
Standardized principle component analysis: slope = 1.02,
intercept = -1.92. Paired t-test: t = 3.98, 2p < 0.001.
Practicability
The time for setting up one sample is 75 min, for 100
samples 180 min and for 200 samples 300 min. The
maximum number of samples is 100 before the AHS
requires a recharge. The application dosage is 0.6 ìÀ per
sample but the capillary blades must be charged with
30-50 ìÀ per sample. At present the AHS can only
analyse sera. Work is in progress on the electrophoretic
determination of proteins in other body fluids. The
odour of decahydronaphthalene has been eliminated by
using granular activated charcoal and an automatic vent
pipe. The handling of AHS is simple. The manufacturer
provides a detailed operating manual as well as a tool
box with hints on minor repairs.
Not considering the initial purchase and other fixed
costs, the following variable costs for a serum electro-
phoretic determination including reagents, control sera,
pertinent supplies and technician's time are about 0.83
DM for AHS and about 1.87 DM with the SMMS in
a series of 100 samples (tab. 5).
Conclusion
AHS showed a significantly better accuracy, pr.acticab-
ility and lower imprecision with regard to manual
systems such as SMMS. Albumin values obtained by
AHS and Beckman ICS showed a good correlation. In
addition, AHS reduced the personal work load thereby
increasing the sample throughput per day and proved
Fig. 4. Histograms representing the distribution of the albumin,
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Tab. 3. Recovery of AHS fractionated albumin-, áÃ, <*2-, â- and ?^globulins in human pooled sera containing various drugs. As controls
a mean value and the range of 3 standard deviations was calculated from 20 electrophoretic determinations of pooled sera.
(Albumin: 0.597-0.628; arGlobulins: 0.029-0.036; a2-Globulins: 0.106-0.115; 0-Globulins: 0.0635-0.0791; ã-Globulins:













































































































































































































































































































































































































É.Í.Í. = International non^proprietary names as proposed by the WHO (13).
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Tab. 5. Comparison of the costs of AHS and SMMS. n = number
of specimens per series.
Total (DM)
AHS SMMS
1 10 100 1 10 100
Technician time1) 1.80 0.60 0.59 6.85 1.74 1.22
(DM)
Reagents, control 6.00 0.60 0.29 2.20 0.77 0.65
sera and pertinent
supplies (DM)
7.80 1.20 0.83 9.05 2.51 1.87
) costs per minute technician time 0.60 DM (14).
to be reliable and easier to maintain than SMMS. The
results of this study showed AHS to be very suitable
for serum protein fractionation.
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